|
Because rheumatoid arthritis presents itself in many different ways, treatment must be tailored to the individual, taking into account the severity of the person's arthritis, other medical conditions a person may have, and their individual lifestyle. Current treatment methods focus on relieving pain, reducing inflammation, stopping or slowing joint damage, and improving a person's functioning and sense of well-being.
Follow the links below to find information about the treatment of rheumatoid arthritis.
Reviewed November 2009
Printer friendly page
Related HealthInsite Topics
| Results 1 to 17 displayed. |
| Title: |
Clinical guidelines for musculoskeletal diseases
|
| Publisher: |
Royal Australasian College of General Practitioners (RACGP)
|
| Description: |
Contents: Clinical practice guidelines for the non-surgical management of hip and knee osteoarthritis; clinical guidelines for the diagnosis and management of early rheumatoid arthritis; clinical guidelines for the diagnosis and management of juvenile idiopathic arthritis
|
| Date: |
Aug 2009
|
| Title: |
Juvenile arthritis in Australia
|
| Publisher: |
Australian Institute of Health and Welfare
|
| Description: |
Juvenile arthritis is one of the common chronic diseases affecting Australian children. The disease contributes significantly to ill health, affecting growth and skeletal maturity of children. The life course of the disease entails a variety of complications, activity limitations and need for regular support and care.
|
| Date: |
Oct 2008
|
| Title: |
Pain relief for children
|
| Publisher: |
Australian Prescriber
|
| Description: |
Paracetamol, ibuprofen and codeine are the most commonly used medicines for treating pain in children. Aspirin is no longer recommended for children under the age of 12.
|
| Date: |
Jun 2008
|
| Title: |
Paediatric analgesia
|
| Publisher: |
Australian Prescriber
|
| Description: |
In Australia, the main analgesic medications used in children in an ambulatory setting are paracetamol, ibuprofen and codeine. There has been significant debate in the literature recently as to which of these is the safest and most effective drug to use in children.
|
| Date: |
Jun 2008
|
| Title: |
Arthritis
|
| Publisher: |
The Jean Hailes Foundation for Women's Health
|
| Description: |
Arthritis literally means 'inflammation of the joint'. There are approximately 150 conditions that can be classified as arthritis. The most common symptoms are pain, swelling and stiffness in one or more joints, and fatigue. Three of the most common types of arthritis are osteoarthritis, rheumatoid arthritis and gout.
|
| Date: |
Sep 2007
|
| Title: |
Exercise Therapy for Arthritis
|
| Publisher: |
HealthInsite Topic Page
|
| Description: |
Links to information on exercise as therapy for arthritis
|
| Date: |
Jan 2007
|
| Title: |
Monoclonal antibody therapy for non-malignant disease
|
| Publisher: |
Australian Prescriber
|
| Description: |
Advances in technology have enabled monoclonal antibodies to be produced which bind to specific antigens associated with disease processes. By targeting these antigens the antibodies can destroy or alter the function of cells which express the target.
|
| Date: |
Oct 2006
|
| Title: |
Rheumatoid arthritis (Comments for Consumers)
|
| Publisher: |
Australian Prescriber
|
| Description: |
Severe rheumatoid arthritis sometimes needs treatment which alters the immune system. This reduces inflammation in the joints. Genetic engineering is making new products to reduce inflammation. Adalimumab, etanercept and infliximab are three of these products.
|
| Date: |
Apr 2004
|
| Title: |
Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis
|
| Publisher: |
Australian Prescriber
|
| Description: |
The last decade has seen a substantial shift in the management of rheumatoid arthritis. It has moved from symptom control to 'designer' therapies, based on the known pathogenesis of rheumatoid arthritis, which alleviate symptoms and retard joint destruction. Three examples of these new therapies are adalimumab, etanercept and infliximab.
|
| Date: |
Apr 2004
|
| Title: |
Disease modifying drugs in rheumatoid arthritis (Comment for Consumers)
|
| Publisher: |
Australian Prescriber
|
| Description: |
Rheumatoid arthritis is a common disease which causes inflammation of the joints. To slow down the damage to the joints, patients are given medicine to reduce the inflammation. It is not possible to say which medicine will be best for which patient. Some people need to take more than one medicine.
|
| Date: |
Apr 2003
|
| Title: |
Disease modifying drugs in adult rheumatoid arthritis
|
| Publisher: |
Australian Prescriber
|
| Description: |
Effective treatment of rheumatoid arthritis now involves starting disease-modifying antirheumatic drugs at the time of diagnosis. This aims to slow development of the irreversible joint damage that leads to long-term disability.
|
| Date: |
Apr 2003
|
| Title: |
The changing treatment of arthritis
|
| Publisher: |
Australian Prescriber
|
| Description: |
Arthritis falls into two very broad categories, which are not mutually exclusive. The most common is osteoarthritis. The other broad category contains inflammatory arthropathies, of which rheumatoid arthritis and psoriatic arthritis are the most common examples.
|
| Date: |
Jan 2000
|
| Results 1 to 17 displayed. |
|
